Key Sessions
Arthur Franken
Charting the Course: The 2024 Investment Landscape for European Biotechs
Gilde Healthcare
Susanne Kreutz
Prescription for Success: Navigating the Dynamic World of Pharma M&A in 2024
Novartis
Marta Lesko
Finding the “Golden Egg”: Forging Partnerships that Transform Technologies into Therapeutic Solutions
Merck
Holger Kissel
The Equation for Maturation: Biotech Requirements to Achieve Scale
BioNtech
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1 – Monday, 29 APRIL - GMT (Greenwich Mean Time, GMTZ)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Formats
Day 1 – Monday, 29 APRIL - GMT (Greenwich Mean Time, GMTZ)
search
Streams
Clear
Formats
Showing 1 of 1 Streams
BIOTECH LEADERS - CAPITAL MARKETS & INVESTMENT
11:10 - 11:50
Charting the Course: The 2024 Investment Landscape for European Biotechs
- Arthur Franken - Managing Partner, Gilde Healthcare
- Woody Stileman - Managing Director, Strategic Partnerships, RTW Investments
- Giovanni Rizzo - Partner Biotech Fund, Indaco Venture Partners
- Claire Brown - Investor, Oxford Science Enterprises
- Natasha Barrow - Reporter, Citeline
- Vanessa Carle - Senior Associate, Forbion
11:50 - 12:10
Fostering Biotech Innovation - A Perspective From Belgium's Ecosystem
- Benoit Kenda - VP and Global Early Solution Partnering, Head, UCB
- Amel Tounsi - CEO, Bridge 2 Health
- Marc Foidart - CEO, EyED pharma
12:10 - 12:50
Navigating the Investment Frontier: Early-Stage Funding for Biotech Innovators
- Daniela Begolo - Managing Director, EQT Life Sciences
- Thomas Thestrup - Principal, Angelini Ventures
- Clara Campàs Moya - Managing Partner & Cofounder, ASABYS PARTNERS
- Sean Kendall - Principal, ARCH Venture Partners
- Audrey Warner - Partner, TigerGene LLC
- Alex Hamilton - Partner, Syncona
Showing 1 of 1 Streams
BIOTECH LEADERS - CAPITAL MARKETS & INVESTMENT
14:00 - 14:40
Accelerating Growth: Investment Strategies for Post Series B Biotech Ventures
- Alastair Hugh Lowell Kilgour - Co-Founder & Chief Investment Officer, Parkwalk Advisors
- Natalie Torin - Managing Director, Dunhill Ventures
- Daniel Parera - Partner, Kurma Partners
- Charles Conn - Managing Partner, Monograph Capital
- Michael White - Head of Life Sciences, HSBC Innovation Bank, EMEA, HSBC
- Alex Hamilton - Partner, Syncona
14:40 - 15:00
Tillotts with a Strong Track Record in Both Partnering and M&A: A Preferred Partner in Europe for Specialty Products
- Ragip Ziyal - Head of Coporate Development, Tillotts Pharma
15:00 - 15:40
Public Biotech Playbook: Navigating the Current State of the Markets
- Herve Kergrohen - Bioscience Focused Venture Partner, ABO
- Max Klement - Principal, Novo Holdings
- Ajan Reginald - CEO, Roquefort Therapeutics
- John Rudy - Member / Co-chair, Securities & Capital Markets Practice, Mintz
- Edouard Guillet - MD, IPF Partners
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
Formats